Santi et al. reported a decrease in proliferation of triple negative breast cancer cells after knockdown of AKT3 [71], whereas Chung et al. did not observe an alteration of proliferation in the AKT3 knockdown, as we reported [67]. The gene discussed is AKT3; the disease is triple-negative breast carcinoma.